|
Constructive Collisions: Neuroscience x Environmental Health
Tuesday, October 11, 2022 | 11:45 AM - 2:00 PM
Rollins School of Public Health, 8th Floor
Lawrence P. & Ann Estes Klamon Room
1518 Clifton Rd. NE, Atlanta, GA 30322
Join us for an in-person, on-campus event that will include two exciting collaboration opportunities to connect researchers working in Neuroscience x Environmental Health.
The Office of SVPR, in partnership with HERCULES Exposome Research Center, Goizueta Institute @ Emory Brain Health, and the Department of Human Genetics, invites Emory researchers who work in environmental health, brain health and the neurosciences, and other related disciplines to attend. Faculty who do not currently work in this space but who are interested are also welcome.
NIH has formally expressed interest in promoting interdisciplinary research and addressing current gaps and opportunities in the intersection of these research areas.
This session will host Lightning Talk presenters who will share brief 10-minute presentations on their ongoing work and future research interests. Following Lighting Talks, we will host a Pitch Session where event attendees will network, collaborate, and brainstorm project ideas that can lead to extramural funding in this area. The event will culminate with each team pitching a real seed project, with up to three teams receiving small, on-the-spot funding to support new collaborations.
**Parking and Box Lunch Included**
| |
|
AI.Humanity with a Social Justice Lens w/ Georgia Tech
Wednesday, November 9th | 3: 00 PM – 6:00 PM
CODA at Tech Square
756 W Peachtree St NW, Atlanta, GA 30308
We invite you to join us at a networking event and pitch competition between Emory University and Georgia Tech on the topic of AI.Humanity with a Social Justice Lens. This event is open to researchers from both universities who currently work in AI and/or Social Justice and those who have an interest in working at the intersection of these areas.
The first half of the event will include structured networking activities to promote dialogue around social justice. Attendees will be encouraged to network, create teams, and brainstorm ideas for new projects. The event will culminate with each team pitching their ideas to receive on-the-spot funding.
Registration opening soon!
| |
|
National Institutes of Health | Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
Supports research to understand health outcomes related to an unexpected and/or time-sensitive event (e.g., emergent environmental threat; pandemic; change in local, state, or national policy; natural disaster) through and accelerated review/award process. Applications must demonstrate that the research proposed is time-sensitive and must be initiated with minimum delay due to a limited window of opportunity to collect baseline data, answer key research questions, and/or prospectively evaluate a new policy or program.
Deadline: Application accepted on a rolling basis
| |
|
National Institutes of Health | Bridge2AI Program
Although there are no current funding opportunities posted, NIH recently announced it will invest $130 million over four years, to accelerate the widespread use of artificial intelligence (AI) by the biomedical and behavioral research communities. Through extensive collaboration across projects, Bridge2AI researchers will create guidance and standards for development of ethically sourced, state-of-the-art, AI-ready data sets that have the potential to help solve some of the most pressing challenges in human health.
| |
|
The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space Clinical Resource (ACR) (U24 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support the development, implementation, and maintenance of the AnVIL Clinical Resource (ACR), a suite of genomic-based clinical tools and services built into the NHGRI Data Science Analysis, Visualization, and Informatics Lab-Space (AnVIL) to foster clinical genomic research. AnVIL is a scalable and interoperable resource for the basic and clinical genomic research communities that leverages a cloud-based infrastructure to democratize data access, sharing, and computing across large genomic and genomic-related datasets.
Submission Deadline: 12/2/2022
| |  |
|
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease
Submission Deadline: 10/16/2022
| |
 | |
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs should address scientific areas relevant to the NIAID mission including: biology and pathogenesis of infectious microbes, including HIV; host-microbe interactions; mechanisms regulating immune system development and function across the lifespan, and in response to infectious pathogens; immune dysfunction resulting in allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each P01 application submitted to this FOA must include at least two related, synergistic research projects that share a common central theme, focus, and/or overall objective; and an administrative core. A P01 may include scientific cores, if needed for the proposed research.
Deadline: 1/11/2023
| | |
|
Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support research on the underlying cause(s) of signs and symptoms that may persist following a Lyme disease diagnosis and antibiotic treatment.
Deadline: 11/8/2022
| |
|
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds (“validated hits”) for chemical optimization and bioassays for testing new analog compounds.
Deadline: 10/16/2022
| | |
| | |
Network for Personalization of Diagnostic Tests for Alzheimer's Disease (AD) and AD-Related Dementias in Older Adults with Multiple Chronic Conditions (MCCs) (U24)
This Funding Opportunity Announcement (FOA) invites applications to establish a network that will conduct transdisciplinary aging diagnostic biomarker and/or imaging research projects focused on Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) in persons living with multiple chronic conditions (MCCs). The aim of the network and its projects is to better align diagnostic testing with the needs and priorities of an aging population. The national consortium will: 1) assemble existing data and acquire real-world data to ensure that the research sample is large with adequate representation of older adults living with well-characterized MCCs, and incorporate pre-specified subgroup analyses; 2) analyze data for performance and accuracy of biomarkers, including blood, cerebrospinal fluid (CSF), and imaging, in older patients living with MCCs; and 3) conduct pilot studies involving specific AD/ADRD imaging and/or biomarkers in persons living with MCCs.
Deadline: 10/17/2022
| |
|
Global Brain Nervous System Disorders Research Across the Lifespan (R01)
This program encourages applications for the conduct of innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system function and disorders throughout life, relevant to LMICs. The collaborative research programs are expected to contribute to the long-term goals of building and strengthening sustainable neuro-health research capacity in LMICs to address brain, nervous system and neuromuscular development, function and impairment throughout life and to lead to diagnostics, treatments, prevention and implementation strategies. The proposed work will also contribute to developing a base for research networking and evidence-based policy beyond the specific research project.
Deadline: 11/15/2022
AIDS Applications: 12/9/2022
| | |
|
Partnership to Advance Conservation Science and Practice (PACSP)
The National Science Foundation (NSF) and the Paul G. Allen Family Foundation (the foundation) are partnering to support a new program, to be administered by NSF, that will support conservation science and science-informed conservation practice in the United States. The objective of the PACSP Program is to support conservation research that investigates organismal biology, ecology, and/or evolution and is designed to contribute to the development and implementation of evidence-based activities and/or technology solutions to advance biodiversity conservation.
Deadline: 10/11/2022
| |
|
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.
Deadline: 2/5/2023
| | |
|
Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)
This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders (specifically people from NIH designated health disparities populations) in T1D research; particularly those from communities that experience diabetes-related health disparities and live within the healthcare and social systems that negatively impact community members’ and patients’ health.
Deadline: 11/17/2022
| |
ARPA-H Seed Funding
To help position Emory faculty for the launch of ARPA-H, the Office of the Sr. Vice President for Research, in consultation with the Office of the Provost, has created the ARPA-H seed funds program. These seeds are intended to lead to competitive ARPA-H proposals. In alignment with ARPA-H’s expected culture and processes, this seed funding aims to rapidly de-risk bold, revolutionary concepts in the biomedical and health sciences.
Given the unique culture of ARPA-H and its reliance on program managers to make funding decisions based on the Heilmeier Questions (and not peer review), awardees will receive tailored training and feedback on their responses to the Heilmeier Questions. During and after the conclusion of the seed project, seed recipients will work with the Office of Research Development to refine their ARPA-H pitch.
Deadline: 10/5/2022
Learn more about ARPA-H
| |
Proposal Development Support for Equipment Proposals
The Office of the SVPR is pleased to offer proposal development support to principal investigators preparing proposals to secure shared research equipment through the National Science Foundation’s Major Research Instrumentation (NSF MRI) program, National Institute of Health’s S10 Shared Instrumentation Grant Program (SIG) or High-End Instrumentation Grant Program (HEI), or similar funding mechanism.
Selected participants will receive proposal development support for the June 2023 (NIH S10), Fall 2023/Jan 2024 (NSF MRI), or other relevant submission deadlines. Please see Emory’s InfoReady portal for additional details and the full Request for Applications.
Deadline: 11/18/2022
| |
Featured Limited Submission Internal Competition | |
NSF Major Research Instrumentation Program
This program is institutionally limited therefore an internal competition must be held. Emory as an institution is limited to three (3) applications for this program. While the overall limit is three (3) applications, Emory may submit no more than two (2) applications in Track 1 and no more than one (1) submission in Track 2.
An MRI award supports the acquisition or development of a multi-user research instrument that is, in general, too costly and/or not appropriate for support through other NSF programs. MRI provides support to acquire critical research instrumentation without which advances in fundamental science and engineering research may not otherwise occur. MRI also provides support to develop next-generation research instruments that open new opportunities to advance the frontiers in science and engineering research.
Deadline: 10/6/2022
| |
DARPA Forward: Advancing the Horizons of National Security
October 25-26
Held at GA Tech, this is a two-day conference featuring panel discussions, lightning talks, and more. Virtual attendance is an option.
View Details & Register
| |
| |
|
Funding Opportunities Calendar | |
A comprehensive archive of past, present, and upcoming opportunities can be found on the SVPR funding calendar. Click the link below to view.
SVPR Funding Calendar
| | | |
|
Limited and Internal Competitions through InfoReady | |
Universities involved in research often need to run competitions for grant funding, whether for internal grant dollars or limited submission opportunities through external sponsors.
If you are interested in submitting a proposal to a funding opportunity with an institutional limitation, please check InfoReady to see if it is listed first. If it is not there, please email limited-opps@emory.edu and include the funding opportunity number, title, and due date.
Link to InfoReady
| | | |
|
Search Tool for Corporate and Foundation Funding Opportunities | |
The Office of Corporate Relations and the Office of Foundation Relations have teamed up to create this resource site to provide a curated list of current funding opportunities and other resources. This site will help promote connections between Emory colleagues and corporate/foundation partners.
Link to SharePoint Search Tool
| | |
|
Free access available with Emory Email address. Formally IRIS. Provides access to the University Community to conduct funding searches. The database is provides funding opportunities for the physical and life sciences, social sciences, arts, and humanities.
Link for More Information
| | |
Grants.gov is a central storehouse for information on over 1,000 grant programs from over 27 federal agencies. Interested applicants can search for relevant funding opportunities by Keyword or Category or browse opportunities by agency. The portal is also a central source to apply for federal grants. Information on the processes for proposal submission through Grants.gov can be found in Proposal Submission. | | | |
|
|
Free access available through Databases@Emory. This database, produced by the nation's leading authority on philanthropy, includes extensive program details for thousands of leading foundations; detailed application guidelines for more than 7,000 grants; and a searchable file of approximately half a million grants.
Link for More Information
| | | | | | |
